Changes to the TDP-43 and FUS Interactomes Induced by DNA Damage.

J Proteome Res

Department of Molecular and Cellular Biology , University of Colorado, Boulder , Colorado 80309 , United States.

Published: January 2020

The RNA-binding proteins TDP-43 and FUS are tied as the third leading known genetic cause for amyotrophic lateral sclerosis (ALS), and TDP-43 proteopathies are found in nearly all ALS patients. Both the natural function and contribution to pathology for TDP-43 remain unclear. The intersection of functions between TDP-43 and FUS can focus attention for those natural functions mostly likely to be relevant to disease. Here, we compare the role played by TDP-43 and FUS, maintaining chromatin stability for dividing HEK293T cells. We also determine and compare the interactomes of TDP-43 and FUS, quantitating changes in those before and after DNA damage. Finally, selected interactions with known importance to DNA damage repair were validated by co-immunoprecipitation assays. This study uncovered TDP-43 and FUS binding to several factors important to DNA repair mechanisms that can be replication-dependent, -independent, or both. These results provide further evidence that TDP-43 has an important role in DNA stability and provide new ways that TDP-43 can bind to the machinery that guards DNA integrity in cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947635PMC
http://dx.doi.org/10.1021/acs.jproteome.9b00575DOI Listing

Publication Analysis

Top Keywords

tdp-43 fus
24
dna damage
12
tdp-43
9
fus
6
dna
6
changes tdp-43
4
fus interactomes
4
interactomes induced
4
induced dna
4
damage rna-binding
4

Similar Publications

Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease, which still lacks effective disease-modifying therapies. Similar to other neurodegenerative disorders, such as Alzheimer and Parkinson disease, ALS pathology is presumed to propagate over time, originating from the motor cortex and spreading to other cortical regions. Exploring early disease stages is crucial to understand the causative molecular changes underlying the pathology.

View Article and Find Full Text PDF

Design principles to tailor Hsp104 therapeutics.

Cell Rep

December 2024

Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Pharmacology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address:

The hexameric AAA+ disaggregase, Hsp104, collaborates with Hsp70 and Hsp40 via its autoregulatory middle domain (MD) to solubilize aggregated proteins. However, how ATP- or ADP-specific MD configurations regulate Hsp104 hexamers remains poorly understood. Here, we define an ATP-specific network of interprotomer contacts between nucleotide-binding domain 1 (NBD1) and MD helix L1, which tunes Hsp70 collaboration.

View Article and Find Full Text PDF

Neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) are characterized by complex etiologies, often involving disruptions in functions of RNA/DNA binding proteins (RDBPs) such as FUS and TDP-43. The cytosolic mislocalization and aggregation of these proteins are linked to accumulation of unresolved stress granules (SGs), which exacerbate the disease progression. Poly-ADP-ribose polymerase (PARP)-mediated PARylation plays a critical role in this pathological cascade, making it a potential target for intervention.

View Article and Find Full Text PDF

Neurodegenerative disorders are characterized by a progressive decline of specific neuronal populations in the brain and spinal cord, typically containing aggregates of one or more proteins. They can result in behavioral alterations, memory loss and a decline in cognitive and motor abilities. Various pathways and mechanisms have been outlined for the potential treatment of these diseases, where redox regulation is considered as one of the most common druggable targets.

View Article and Find Full Text PDF

Frontotemporal Dementia.

Continuum (Minneap Minn)

December 2024

Article Synopsis
  • - The article outlines frontotemporal dementia (FTD) by focusing on three core syndromes: behavioral variant FTD and two types of progressive aphasia (nonfluent and semantic variants), which are linked to specific protein abnormalities in the brain.
  • - It highlights that FTD is more heritable than Alzheimer's and indicates genetic variations, such as in C9orf72 and MAPT, are found in over 10% of cases, which help understand its pathology through clinical presentations and imaging.
  • - Although there are no FDA-approved treatments for FTD yet, ongoing clinical trials aim to find disease-modifying therapies, while current management strategies address behavioral and language issues through non-drug methods or off-label medication use. *
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!